Please enable JavaScript to continue using this application.

Compare $CTOR vs $OSTX | Chartloom

Compare

$CTOR vs $OSTX

Citius Oncology Inc · OS Therapies Inc

CTOR

Citius Oncology Inc

OSTX

OS Therapies Inc

Compare $CTOR vs $OSTX

Comparing Citius Oncology Inc and OS Therapies Inc

CTORCitius Oncology Inc

OSTXOS Therapies Inc

CTORCitius Oncology Inc

Market cap

$78M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.10x

Rev growth (TTM)

—

YTD performance

-22.2%

52W performance

-54.4%

FCF yield

-24.8%

OSTXOS Therapies Inc

Market cap

$74M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

20.9%

52W performance

-20.6%

FCF yield

-25.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CTOR

OSTX

Detailed metrics comparison

CTOR

Citius Oncology Inc

OSTX

OS Therapies Inc

Market Cap

CTOR$78M

OSTX$74M

Enterprise Value

CTOR$72M

OSTX$74M

Price

CTOR$0.84

OSTX$1.62

P/E Ratio

CTORN/A

OSTXN/A

P/S Ratio

CTOR10.99x

OSTX0.00x

EV/Sales

CTOR10.10x

OSTX0.00x

EV/EBITDA

CTOR0.00x

OSTX0.00x

P/B Ratio

CTOR2.19x

OSTX16.11x

P/FCF Ratio

CTORN/A

OSTXN/A

EV/FCF

CTOR-3.70x

OSTX-3.97x

PEG Ratio

CTORN/A

OSTXN/A

Forward P/E (NTM)

CTORN/A

OSTXN/A

Forward P/S (NTM)

CTOR1.10x

OSTXN/A

Revenue (TTM)

CTOR$7M

OSTX$0

Revenue Growth (YoY)

CTORN/A

OSTXN/A

Forward Rev Growth

CTOR65.4%

OSTX534.8%

Gross Margin (TTM)

CTOR77.3%

OSTX0.0%

Operating Margin (TTM)

CTOR0.0%

OSTX0.0%

EBITDA Margin (TTM)

CTOR-542.8%

OSTX0.0%

Net Margin (TTM)

CTOR-648.3%

OSTX0.0%

FCF Margin (TTM)

CTOR-272.9%

OSTXN/A

Net Income (TTM)

CTOR$-46M

OSTX$-39M

FCF (TTM)

CTOR$-19M

OSTX$-19M

EPS (TTM)

CTOR-$0.43

OSTX-$0.90

ROE (TTM)

CTOR-10298.0%

OSTX-56759.0%

ROA (TTM)

CTOR-4349.0%

OSTX-47736.0%

ROIC (TTM)

CTOR-9188.0%

OSTX-56759.0%

Cash

CTOR$17M

OSTX$205K

Debt

CTOR$10M

OSTX$0

Net Cash/Debt

CTOR$6M

OSTX$205K

Current Ratio (TTM)

CTOR0.73x

OSTX0.18x

Quick Ratio (TTM)

CTOR0.29x

OSTX0.16x

Debt/Equity (TTM)

CTOR0.25x

OSTX0.00x

Debt/Assets (TTM)

CTOR0.0%

OSTX0.0%

Interest Coverage (TTM)

CTORN/A

OSTXN/A

Net Debt/EBITDA (TTM)

CTOR0.00x

OSTX0.00x

Beta

CTOR3.34

OSTX1.36

52W Performance

CTOR-54.4%

OSTX-20.6%

YTD Performance

CTOR-22.2%

OSTX20.9%

% from 52W High

CTOR-62.7%

OSTX-28.0%

% from 52W Low

CTOR71.0%

OSTX40.9%

Asset Turnover (TTM)

CTOR0.00x

OSTX0.00x

FCF Yield (TTM)

CTOR-24.8%

OSTX-25.1%

Earnings Yield (TTM)

CTOR-59.0%

OSTX-53.4%

Dividend Yield (TTM)

CTORN/A

OSTXN/A

Rule of 40

CTOR-272.9

OSTX0.0

EV/GP/RG

CTOR0.01

OSTXN/A

Ticker research

View CTOR research View OSTX research

Metric	CTOR Citius Oncology Inc	OSTX OS Therapies Inc
Market & Valuation
Market Cap	$78M	$74M
Enterprise Value	$72M	$74M
Price	$0.84	$1.62
P/E Ratio	N/A	N/A
P/S Ratio	10.99x	0.00x
EV/Sales	10.10x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.19x	16.11x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.70x	-3.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.10x	N/A
Revenue & Growth
Revenue (TTM)	$7M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	65.4%	534.8%
Profitability
Gross Margin (TTM)	77.3%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-542.8%	0.0%
Net Margin (TTM)	-648.3%	0.0%
FCF Margin (TTM)	-272.9%	N/A
Net Income (TTM)	$-46M	$-39M
FCF (TTM)	$-19M	$-19M
EPS (TTM)	-$0.43	-$0.90
ROE (TTM)	-10298.0%	-56759.0%
ROA (TTM)	-4349.0%	-47736.0%
ROIC (TTM)	-9188.0%	-56759.0%
Financial Health
Cash	$17M	$205K
Debt	$10M	$0
Net Cash/Debt	$6M	$205K
Current Ratio (TTM)	0.73x	0.18x
Quick Ratio (TTM)	0.29x	0.16x
Debt/Equity (TTM)	0.25x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.34	1.36
52W Performance	-54.4%	-20.6%
YTD Performance	-22.2%	20.9%
% from 52W High	-62.7%	-28.0%
% from 52W Low	71.0%	40.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-24.8%	-25.1%
Earnings Yield (TTM)	-59.0%	-53.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-272.9	0.0
EV/GP/RG	0.01	N/A
Ticker research	View CTOR research	View OSTX research

Valuation

P/S Ratio

OSTX

0.00x

CTOR

10.99x

EV/FCF

OSTX

-3.97x

CTOR

-3.70x

Growth & revenue

Forward Revenue Growth

OSTX

534.8%

CTOR

65.4%

Profitability & performance

Gross Margin

CTOR

77.3%

OSTX

0.0%

ROE

CTOR

-10298.0%

OSTX

-56759.0%

FCF Yield %

CTOR

-24.8%

OSTX

-25.1%

52-Week Performance

OSTX

-20.6%

CTOR

-54.4%

Detailed metrics comparison

CTOR

Citius Oncology Inc

OSTX

OS Therapies Inc

Market Cap

CTOR$78M

OSTX$74M

Enterprise Value

CTOR$72M

OSTX$74M

Price

CTOR$0.84

OSTX$1.62

P/E Ratio

CTORN/A

OSTXN/A

P/S Ratio

CTOR10.99x

OSTX0.00x

EV/Sales

CTOR10.10x

OSTX0.00x

EV/EBITDA

CTOR0.00x

OSTX0.00x

P/B Ratio

CTOR2.19x

OSTX16.11x

P/FCF Ratio

CTORN/A

OSTXN/A

EV/FCF

CTOR-3.70x

OSTX-3.97x

PEG Ratio

CTORN/A

OSTXN/A

Forward P/E (NTM)

CTORN/A

OSTXN/A

Forward P/S (NTM)

CTOR1.10x

OSTXN/A

Revenue (TTM)

CTOR$7M

OSTX$0

Revenue Growth (YoY)

CTORN/A

OSTXN/A

Forward Rev Growth

CTOR65.4%

OSTX534.8%

Gross Margin (TTM)

CTOR77.3%

OSTX0.0%

Operating Margin (TTM)

CTOR0.0%

OSTX0.0%

EBITDA Margin (TTM)

CTOR-542.8%

OSTX0.0%

Net Margin (TTM)

CTOR-648.3%

OSTX0.0%

FCF Margin (TTM)

CTOR-272.9%

OSTXN/A

Net Income (TTM)

CTOR$-46M

OSTX$-39M

FCF (TTM)

CTOR$-19M

OSTX$-19M

EPS (TTM)

CTOR-$0.43

OSTX-$0.90

ROE (TTM)

CTOR-10298.0%

OSTX-56759.0%

ROA (TTM)

CTOR-4349.0%

OSTX-47736.0%

ROIC (TTM)

CTOR-9188.0%

OSTX-56759.0%

Cash

CTOR$17M

OSTX$205K

Debt

CTOR$10M

OSTX$0

Net Cash/Debt

CTOR$6M

OSTX$205K

Current Ratio (TTM)

CTOR0.73x

OSTX0.18x

Quick Ratio (TTM)

CTOR0.29x

OSTX0.16x

Debt/Equity (TTM)

CTOR0.25x

OSTX0.00x

Debt/Assets (TTM)

CTOR0.0%

OSTX0.0%

Interest Coverage (TTM)

CTORN/A

OSTXN/A

Net Debt/EBITDA (TTM)

CTOR0.00x

OSTX0.00x

Beta

CTOR3.34

OSTX1.36

52W Performance

CTOR-54.4%

OSTX-20.6%

YTD Performance

CTOR-22.2%

OSTX20.9%

% from 52W High

CTOR-62.7%

OSTX-28.0%

% from 52W Low

CTOR71.0%

OSTX40.9%

Asset Turnover (TTM)

CTOR0.00x

OSTX0.00x

FCF Yield (TTM)

CTOR-24.8%

OSTX-25.1%

Earnings Yield (TTM)

CTOR-59.0%

OSTX-53.4%

Dividend Yield (TTM)

CTORN/A

OSTXN/A

Rule of 40

CTOR-272.9

OSTX0.0

EV/GP/RG

CTOR0.01

OSTXN/A

Ticker research

View CTOR research View OSTX research

Metric	CTOR Citius Oncology Inc	OSTX OS Therapies Inc
Market & Valuation
Market Cap	$78M	$74M
Enterprise Value	$72M	$74M
Price	$0.84	$1.62
P/E Ratio	N/A	N/A
P/S Ratio	10.99x	0.00x
EV/Sales	10.10x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.19x	16.11x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.70x	-3.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.10x	N/A
Revenue & Growth
Revenue (TTM)	$7M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	65.4%	534.8%
Profitability
Gross Margin (TTM)	77.3%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-542.8%	0.0%
Net Margin (TTM)	-648.3%	0.0%
FCF Margin (TTM)	-272.9%	N/A
Net Income (TTM)	$-46M	$-39M
FCF (TTM)	$-19M	$-19M
EPS (TTM)	-$0.43	-$0.90
ROE (TTM)	-10298.0%	-56759.0%
ROA (TTM)	-4349.0%	-47736.0%
ROIC (TTM)	-9188.0%	-56759.0%
Financial Health
Cash	$17M	$205K
Debt	$10M	$0
Net Cash/Debt	$6M	$205K
Current Ratio (TTM)	0.73x	0.18x
Quick Ratio (TTM)	0.29x	0.16x
Debt/Equity (TTM)	0.25x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.34	1.36
52W Performance	-54.4%	-20.6%
YTD Performance	-22.2%	20.9%
% from 52W High	-62.7%	-28.0%
% from 52W Low	71.0%	40.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-24.8%	-25.1%
Earnings Yield (TTM)	-59.0%	-53.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-272.9	0.0
EV/GP/RG	0.01	N/A
Ticker research	View CTOR research	View OSTX research